A Multicenter Randomized Trial Assessing ZENFlow Carrier-Free Drug-Coated Balloon for the Treatment of Femoropopliteal Artery Lesions

A Multicenter Randomized Trial Assessing ZENFlow Carrier-Free Drug-Coated Balloon for the Treatment of Femoropopliteal Artery Lesions

Backgrounds and ObjectivesDrug-coated balloons (DCBs) have shown promising benefits in improving the outcomes for patients with peripheral artery disease. Several randomized clinical trials have reported that paclitaxel-coated balloon significantly reduce the rates of restenosis and the need for rei...

Full description

Bibliographic Details
Main Authors:	Leng Ni, Wei Ye, Lan Zhang, Xing Jin, Chang Shu, Jin-song Jiang, Mu Yang, Dan-ming Wu, Ming Li, Guan-feng Yu, Jun Yang, Jian-hua Huang, Xiao-bai Wang, Xiao-qiang Li, Wei-liang Jiang, Zhi-qun Wu, Chang-wei Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	drug-coated balloon paclitaxel percutaneous transluminal angioplasty restenosis peripheral artery disease femoropopliteal artery occlusive disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.821672/full

Similar Items

Paclitaxel-Coated versus Uncoated Balloon for Femoropopliteal In-Stent Restenosis: A Systematic Review and Meta-Analysis
by: Qiwei Li, et al.
Published: (2022-09-01)

Five-Year Outcomes of Post-Drug-Coated Balloon Angioplasty Dissection in Complex Femoropopliteal Artery Disease
by: Ren H, et al.
Published: (2021-08-01)

Vessel Patency and Associated Factors of Drug‐Coated Balloon for Femoropopliteal Lesion
by: Yoshimitsu Soga, et al.
Published: (2023-01-01)

Neutrophil-to-Lymphocyte Ratio Predicts Restenosis After Drug-Coated Balloon Therapy for Femoropopliteal Artery Lesions: A Retrospective Study
by: Zhihong Wang, et al.
Published: (2022-07-01)

Comparison of efficacy and safety of drug-eluting versus uncoated balloon angioplasty for femoropopliteal arterial occlusive disease: a meta-analysis
by: Hai Feng, et al.
Published: (2020-08-01)

Current treatment methods for long occlusions of the femoropopliteal segment in patients with intermittent claudication: Minireview
by: Jana Fialova, et al.
Published: (2015-06-01)

Two-year clinical outcomes of drug-coated balloon angioplasty and angiographic predictors of restenosis among patients with de novo femoropopliteal lesions
by: Kohei Yamaguchi, et al.
Published: (2023-11-01)

Restenosis of the femoropopliteal artery after percutaneous transluminal angioplasty
by: Vladka Salapura, et al.
Published: (2014-05-01)

Midterm outcome of directional atherectomy versus plain balloon angioplasty with adjunctive stenting for femoropopliteal artery lesions: A single-center experience
by: Yang Li, et al.
Published: (2020-01-01)

Propensity score-matched analysis of six-month outcomes of paclitaxel-coated balloons combined with UltraScore balloons versus conventional scoring balloons for femoropopliteal lesions
by: Takuya Haraguchi, et al.
Published: (2023-05-01)

Evaluation of Femoropopliteal In-Stent Restenosis Characteristics Stratified by Stent Design
by: Elias Noory, et al.
Published: (2023-11-01)

Case report: Unusual persistent hypotension and acute occlusion after peripheral paclitaxel balloon angioplasty
by: Lin Yang, et al.
Published: (2022-10-01)

Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial
by: Ulf Teichgräber, et al.
Published: (2021-09-01)

Long coverage with drug-eluting stents is superior to spot coverage for long femoropopliteal artery disease: PARADE II study
by: Jong-Il Park, et al.
Published: (2022-10-01)

Increased plasma cathepsin S at the time of percutaneous transluminal angioplasty is associated with 6-months' restenosis of the femoropopliteal artery
by: Božić-Mijovski Mojca, et al.
Published: (2018-01-01)

Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
by: Kazunori Horie, et al.
Published: (2021-01-01)

Drug-Coated Balloon for the Treatment of Femoropopliteal Tosaka Class III In-stent Restenosis Lesions
by: Bihui Zhang, et al.
Published: (2021-01-01)

Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions
by: Liqiang Li, et al.
Published: (2022-09-01)

ISAR‐PEBIS (Paclitaxel‐Eluting Balloon Versus Conventional Balloon Angioplasty for In‐Stent Restenosis of Superficial Femoral Artery): A Randomized Trial
by: Ilka Ott, et al.
Published: (2017-07-01)

Critical appraisal of paclitaxel balloon angioplasty for femoral–popliteal arterial disease
by: Herten M, et al.
Published: (2016-08-01)

Utility of sirolimus coated balloons in the peripheral vasculature – a review of the current literature
by: Y. L. Linn, et al.
Published: (2022-06-01)

Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
by: Konstantinos Katsanos, et al.
Published: (2018-12-01)

Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
by: Takuya Haraguchi, et al.
Published: (2024-02-01)

Clinical outcome of drug-coated balloons in patients with femoropopliteal chronic total occlusive lesions: results from the multicenter EAGLE study
by: Naoki Hayakawa, et al.
Published: (2022-10-01)

One-year outcomes of drug-coated balloon treatment for long femoropopliteal lesions: a multicentre cohort and real-world study
by: Xiaoxi Yu, et al.
Published: (2021-07-01)

Long-term outcome and factors associated with restenosis after combination therapy of balloon angioplasty and stenting for symptomatic intracranial stenosis
by: Toshihiro Ueda, et al.
Published: (2022-12-01)

A pilot study of a novel paclitaxel-coated angioplasty catheter for lower extremity peripheral artery disease: a pilot study
by: Serpil Şahin, et al.
Published: (2023-04-01)

Intraoperative Extravascular Ultrasound in the Identification of Flow-Limiting Dissections after Balloon Angioplasty in the Femoropopliteal Segment
by: Bibombe Patrice Mwipatayi, et al.
Published: (2024-03-01)

Markers of Restenosis after Percutaneous Transluminal Balloon Angioplasty in Patients with Critical Limb Ischemia
by: Elvira V. Sobolevskaya, et al.
Published: (2023-05-01)

Research progress of drug eluting balloon in arterial circulatory system
by: Keji Lu, et al.
Published: (2024-03-01)

Platelet to lymphocyte ratio predicting 6-month primary patency of drug-coated balloon for femoropopliteal disease
by: Yanhua Zhen, et al.
Published: (2020-01-01)

Self-expanding nitinol stents of high versus low chronic outward force in de novo femoropopliteal occlusive arterial lesions (BIOFLEX-COF trial): study protocol for a randomized controlled trial
by: Alexander Wressnegger, et al.
Published: (2017-12-01)

Red blood cell distribution width predicts 1-month complications after percutaneous transluminal angioplasty
by: Veraldi-Franco Gian, et al.
Published: (2019-01-01)

Assessment of Mortality and Factors Affecting Outcome of Use of Paclitaxel-Coated Stents and Bare Metal Stents in Femoropopliteal PAD
by: Aleksander Falkowski, et al.
Published: (2020-07-01)

Drug-coated Balloons in the Neurovascular Setting: A Comprehensive, Systematic Review of Current Use and Indications
by: Philipp von Gottberg, et al.
Published: (2022-04-01)

Postangioplasty restenosis: a practical model in the porcine carotid artery
by: P.R.A. Caramori, et al.
Published: (1997-09-01)

Safety of balloon angioplasty for symptomatic intracranial artery stenosis
by: Yu-jie SUN, et al.
Published: (2019-10-01)

Algorithm of Femoropopliteal Endovascular Treatment
by: Maxime Dubosq, et al.
Published: (2022-09-01)

Early and mid-term results of surgical and endovascular intervention in total occlusion of superficial femoral artery: Which one is better?
by: Mihriban Yalcin, et al.
Published: (2019-01-01)

IN.PACTTM AdmiralTM drug-coated balloons in peripheral artery disease: current perspectives
by: Torii S, et al.
Published: (2019-02-01)